Fundz

Renovacor, Inc. reported raising $3.8 Million in an initial SEC Form D filing, from an offering of $11.1 Million

PRIVATEOct 15, 2019$3.8M of $11.1M raised

Amount Raised

$3.8 Million

$3.8 Million sold, per SEC Form D (first sale Oct 15, 2019)

Round Type

Seed

GreenwhichBiotechnologyHealth CareGeneticsTherapeutics

Quick answer

Renovacor, Inc. raised $3.8 Million in a Seed round, dated October 15, 2019. Renovacor, Inc. is based in Greenwhich, Connecticut, United States.

How much did Renovacor, Inc. raise?
Renovacor, Inc. raised $3.8 Million in a Seed round on October 15, 2019.
What does Renovacor, Inc. do?
Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases.
Where is Renovacor, Inc. based and how big is it?
Renovacor, Inc. is based in Greenwhich, Connecticut, United States.

Source: Fundz verified event record.

Who else raised in Genetics and Therapeutics around the same time

Companies in the same sectors as Renovacor, Inc. that raised within 45 days of this round, from Fundz verified event records.

  • miRecule raised $1.5M (Seed) on November 6, 2019.
  • Passage Bio raised $110M on September 6, 2019.
  • CERo Therapeutics Holdings raised $43M on November 27, 2019.
  • Viome raised $36M on November 27, 2019.
  • Sarepta Therapeutics raised $30M on November 25, 2019.
  • Palvella Therapeutics, Inc. raised $32M on November 20, 2019.

Who to call at Renovacor, Inc., and when

A new round usually means Renovacor, Inc. is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Renovacor, Inc. raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Renovacor, Inc., from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Renovacor, Inc.. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Renovacor, Inc.

Location

5 MEAD POINT DRIVE

Greenwhich, Connecticut, United States

About

Renovacor is a biotechnology company focused on delivering innovative precision therapies to improve the lives of patients and families battling genetically-driven cardiovascular and mechanistically-related diseases. The company’s lead program in BAG3-associated dilated cardiomyopathy (DCM) uses gene transfer technology to address the monogenic cause of this severe form of heart failure. Renovacor’s vision is to bring life-changing therapies to patients living with serious genetic cardiovascular and related diseases, by developing medicines that target the underlying cause of disease and provide a transformative benefit and significant improvement to quality of life.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Renovacor, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Predictive Intelligence
Strategic

ML-powered predictions for Renovacor, Inc.'s next move

See what Strategic adds

Renovacor, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.